The Best GLP-1 Drug on the Market Is Even Better Than We Knew
Summary
A pair of new studies suggest tirzepatide can keep heart disease at bay in high-risk groups.
Description
A pair of new studies suggest tirzepatide can keep heart disease at bay in high-risk groups.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source